A modified human ELISPOT assay to detect specific responses to primary tumor cell targets

A modified human ELISPOT assay to detect specific responses to primary tumor cell targets

<p>Abstract</p> <p>Background</p> <p>The desired outcome of cancer vaccination is to induce a potent T cell response which can specifically recognize and eliminate autologous tumor cells <it>in vivo</it>. Accordingly, immunological assays that demonstrate re...

Full description

Bibliographic Details
Main Authors:	Kwak Larry W, Baseler Michael, Troke Angela, Ulderich Tracy, Shafer-Weaver Kimberly A, Strobl Susan L, Malyguine Anatoli, Neelapu Sattva S
Format:	Article
Language:	English
Published:	BMC 2004-03-01
Series:	Journal of Translational Medicine
Online Access:	http://www.translational-medicine.com/content/2/1/9

Similar Items

The Granzyme B ELISPOT assay: an alternative to the <sup>51</sup>Cr-release assay for monitoring cell-mediated cytotoxicity
by: Baseler Michael, et al.
Published: (2003-12-01)

Evaluating the cytotoxicity of innate immune effector cells using the GrB ELISPOT assay
by: Baseler Michael, et al.
Published: (2004-09-01)

ELISPOT Assay for Monitoring Cytotoxic T Lymphocytes (CTL) Activity in Cancer Vaccine Clinical Trials
by: Thomas J. Sayers, et al.
Published: (2012-05-01)

Cultured ELISpot assay to investigate dengue virus specific T-cell responses
by: Jeewandara, C, et al.
Published: (2018)

Development of an EliSPOT assay for detection of CMV-specific immune response
by: Maria Elena Terlizzi, et al.
Published: (2010-06-01)

ELISPOT assay of the SARS-CoV-2 specific T cells immune response
by: V. V. Gerasimova, et al.
Published: (2022-12-01)

Dissecting the T Cell Response: Proliferation Assays vs. Cytokine Signatures by ELISPOT
by: Magdalena Tary-Lehmann, et al.
Published: (2012-05-01)

ELISPOT Cell Analysis Assay: Searching for Extracellular Footprints
by: Alexander E. Kalyuzhny
Published: (2011-09-01)

An Enhanced ELISPOT Assay for Sensitive Detection of Antigen-Specific T Cell Responses to Borrelia burgdorferi
by: Gottfried H. Kellermann, et al.
Published: (2013-09-01)

Sensitivity and specificity of tritiated thymidine incorporation and ELISPOT assays in identifying antigen specific T cell immune responses
by: MacLeod Beth, et al.
Published: (2007-09-01)

Effect of cryopreservation of peripheral blood mononuclear cells (PBMCs) on the variability of an antigen-specific memory B cell ELISpot: Variability of the memory B cell ELISpot assay.
by: Trück, J, et al.
Published: (2014)

Resting of Cryopreserved PBMC Does Not Generally Benefit the Performance of Antigen-Specific T Cell ELISPOT Assays
by: Ramu A. Subbramanian, et al.
Published: (2012-07-01)

Stepping up ELISpot: Multi-Level Analysis in FluoroSpot Assays
by: Sylvia Janetzki, et al.
Published: (2014-11-01)

Role of ELISPOT Assays in Risk Assessment Pre- and Post-Kidney Transplantation
by: Anat R. Tambur, et al.
Published: (2012-05-01)

Equivalence of ELISpot assays demonstrated between major HIV network laboratories.
by: Dilbinder K Gill, et al.
Published: (2010-12-01)

Immune response in acute hepatitis C: Enumeration of virus specific CD8+T cells with ELISPOT assay and tetramers
by: Gruener, N, et al.
Published: (1999)

Novel M. tuberculosis specific IL-2 ELISpot assay discriminates adult patients with active or latent tuberculosis.
by: Chiara Della Bella, et al.
Published: (2018-01-01)

Modified vaccinia Ankara expressing HIVA antigen stimulates HIV-1-specific CD8 T cells in ELISpot assays of HIV-1 exposed infants.
by: Slyker, J, et al.
Published: (2005)

Pretransplant BKV-IgG serostatus and BKV-specific ELISPOT assays to predict BKV infection after kidney transplantation
by: Hyunjoo Bae, et al.
Published: (2023-09-01)

Cytomegalovirus (CMV)-Specific Perforin and Granzyme B ELISPOT Assays Detect Reactivation of CMV Infection in Inflammatory Bowel Disease
by: Paul V. Lehmann, et al.
Published: (2012-04-01)

Novel sporozoite-based ELISpot assay to assess frequency of parasite-specific B cells after vaccination with irradiated sporozoites
by: Tanmaya Atre, et al.
Published: (2019-05-01)

Comparision of Tuberculin Skin Test and RD1-ELISPOT Assay in Health Care Workers
by: Ahmet SOYSAL, et al.
Published: (2005-09-01)

Increased detection of proliferating, polyfunctional, HIV-1-specific T cells in DNA-modified vaccinia virus Ankara-vaccinated human volunteers by cultured IFN-gamma ELISPOT assay.
by: Winstone, N, et al.
Published: (2009)

Potential role of M. tuberculosis specific IFN-γ and IL-2 ELISPOT assays in discriminating children with active or latent tuberculosis.
by: Elena Chiappini, et al.
Published: (2012-01-01)

Therapy of Newly Diagnosed Follicular Lymphoma
by: Jason R. Westin, et al.
Published: (2012-12-01)

Assessment of T-dependent and T-independent immune responses in cattle using a B cell ELISPOT assay.
by: Grant, C, et al.
Published: (2012)

ELISPOT Assays in 384-Well Format: Up to 30 Data Points with One Million Cells
by: Jodi Hanson, et al.
Published: (2015-01-01)

Assessment of T-dependent and T-independent immune responses in cattle using a B cell ELISPOT assay
by: Grant Clare FJ, et al.
Published: (2012-10-01)

Characterization of Varicella-Zoster (VZV) Specific T Cell Response in Healthy Subjects and Transplanted Patients by Using Enzyme Linked Immunospot (ELISpot) Assays
by: Irene Cassaniti, et al.
Published: (2021-08-01)

Cultured enzyme-linked immunospot assay (ELISPOT) enhances detection of low HIV-specific immune responses in exposed seronegative individuals in Kenya
by: Anzala Omu, et al.
Published: (2006-12-01)

ELISPOT and functional T cell analyses using HLA mono-specific target cells.
by: Horlock, C, et al.
Published: (2009)

Editorial: CAR T-Cell Therapies in Hematologic Tumors
by: Marta Coscia, et al.
Published: (2020-10-01)

Cytomegalovirus (CMV) immune monitoring with ELISPOT and QuantiFERON-CMV assay in seropositive kidney transplant recipients.
by: Hyeyoung Lee, et al.
Published: (2017-01-01)

Nuclear translocation of B-cell-specific transcription factor, BACH2, modulates ROS mediated cytotoxic responses in mantle cell lymphoma.
by: Zheng Chen, et al.
Published: (2013-01-01)

A recombinant vaccinia virus based ELISPOT assay detects high frequencies of Pol-specific CD8 T cells in HIV-1-positive individuals.
by: Larsson, M, et al.
Published: (1999)

Routine evaluation of HBV-specific T cell reactivity in chronic hepatitis B using a broad-spectrum T-cell epitope peptide library and ELISpot assay
by: Yandan Wu, et al.
Published: (2024-03-01)

Comparison of Cytomegalovirus-Specific Immune Cell Response to Proteins versus Peptides Using an IFN-γ ELISpot Assay after Hematopoietic Stem Cell Transplantation
by: Eva Wagner-Drouet, et al.
Published: (2021-02-01)

B-cell ELISpot assay to analyze human memory B cell and plasmablast responses specific to SARS-CoV-2 receptor-binding domain
by: Angeline Rouers, et al.
Published: (2023-03-01)

B-cell ELISpot assay to analyze human memory B cell and plasmablast responses specific to SARS-CoV-2 receptor-binding domain
by: Rouers, Angeline, et al.
Published: (2023)

Harmonization and qualification of an IFN-γ Enzyme-Linked ImmunoSpot assay (ELISPOT) to measure influenza-specific cell-mediated immunity within the FLUCOP consortium
by: Gwenn Waerlop, et al.
Published: (2022-09-01)